IMCR logo

Immunocore Holdings (IMCR) EBITDA

annual EBITDA:

-$29.89M+$21.76M(+42.13%)
December 31, 2024

Summary

  • As of today (June 27, 2025), IMCR annual EBITDA is -$29.89 million, with the most recent change of +$21.76 million (+42.13%) on December 31, 2024.
  • During the last 3 years, IMCR annual EBITDA has risen by +$136.83 million (+82.07%).
  • IMCR annual EBITDA is now at all-time high.

Performance

1-year change

+42.13%

3-year change

+82.07%

5-year change

+79.86%

15-year change

+70.79%

IMCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

40.29%
IMCR annual EBITDA is higher than 40.29% of companies in Healthcare sector

Range

All-time high

-$29.89M
IMCR annual EBITDA is currently at an all-time high

3-year low

-$166.72M

Earnings dates

Last annual earnings report date

Dec 31, 2024
IMCR previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
IMCR next annual earnings announcement has not yet been scheduled

OtherIMCRincome statement metrics

Annual revenue

$310.20M
IMCR annual revenue is $310.20 million

annual net income

-$51.09M
IMCR annual net profit is -$51.09 million

annual EBIT

-$34.09M
IMCR annual earnings before interest & taxes is -$34.09 million

Annual EPS

-$1.02
IMCR annual earnings per share is -$1.02

quarterly EBITDA:

$9.96M+$25.24M(+165.23%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR quarterly EBITDA is $9.96 million, with the most recent change of +$25.24 million (+165.23%) on March 31, 2025.
  • Over the past year, IMCR quarterly EBITDA has increased by +$29.79 million (+150.24%).
  • IMCR quarterly EBITDA is now -8.65% below its all-time high of $10.91 million, reached on September 30, 2024.

Performance

3-month change

+165.23%

1-year change

+150.24%

3-year change

+151.35%

5-year change

+142.93%

IMCR quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

80.7%
IMCR quarterly EBITDA is higher than 80.7% of companies in Healthcare sector

Range

All-time high

$10.91M
IMCR quarterly EBITDA is currently -8.65% below its historical high of $10.91 million

3-year low

-$23.30M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
IMCR previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
IMCR next earnings announcement is scheduled for Aug 8, 2025

OtherIMCRincome statement metrics

Quarterly revenue

$93.88M
IMCR quarterly revenue is $93.88 million

quarterly net income

$5.02M
IMCR quarterly net profit is $5.02 million

quarterly EBIT

$9.11M
IMCR quarterly earnings before interest & taxes is $9.11 million

Quarterly EPS

$0.10
IMCR quarterly earnings per share is $0.10

TTM EBITDA:

$222.00K+$29.79M(+100.75%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR TTM EBITDA is $222.00 thousand, with the most recent change of +$29.79 million (+100.75%) on March 31, 2025.
  • Over the past year, IMCR TTM EBITDA has increased by +$54.74 million (+100.41%).
  • IMCR TTM EBITDA is now at all-time high.

Performance

3-month change

+100.75%

1-year change

+100.41%

3-year change

+100.15%

5-year change

+100.34%

IMCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

76.11%
IMCR TTM EBITDA is higher than 76.11% of companies in Healthcare sector

Range

All-time high

$222.00K
IMCR TTM EBITDA is currently at an all-time high

3-year low

-$147.10M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
IMCR previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 8, 2025
IMCR next earnings announcement is scheduled for Aug 8, 2025

OtherIMCRincome statement metrics

TTM revenue

$333.58M
IMCR TTM revenue is $333.58 million

TTM net income

-$21.63M
IMCR TTM net profit is -$21.63 million

TTM EBIT

-$3.83M
IMCR TTM earnings before interest & taxes is -$3.83 million

TTM EPS

-$0.43
IMCR TTM earnings per share is -$0.43

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

-$29.89M
IMCR annual EBITDA is -$29.89 million

annual net income

-$51.09M
IMCR annual net profit is -$51.09 million

annual interest expense

$18.84M
IMCR annual interest expense is $18.84 million

annual income tax

-$1.85M
IMCR annual income tax is -$1.85 million

annual D&A

$4.20M
IMCR annual depreciation & amortization is $4.20 million

IMCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+42.1%+150.2%+100.4%
3 y3 years+82.1%+151.3%+100.2%
5 y5 years+79.9%+142.9%+100.3%

IMCR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+82.1%-8.7%+142.8%at high+100.2%
5 y5-yearat high+82.1%-8.7%+122.0%at high+100.1%
alltimeall timeat high+82.1%-8.7%+122.0%at high+100.1%

IMCR EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$9.96M(-165.2%)
$222.00K(-100.8%)
Dec 2024
-$29.89M(-42.1%)
-$15.27M(-240.0%)
-$29.57M(-21.3%)
Sep 2024
-
$10.91M(-303.0%)
-$37.60M(-17.1%)
Jun 2024
-
-$5.37M(-72.9%)
-$45.37M(-16.8%)
Mar 2024
-
-$19.83M(-14.9%)
-$54.52M(+5.6%)
Dec 2023
-$51.65M(+71.4%)
-$23.30M(-844.6%)
-$51.65M(+13.9%)
Sep 2023
-
$3.13M(-121.5%)
-$45.33M(+14.6%)
Jun 2023
-
-$14.52M(-14.4%)
-$39.57M(+25.3%)
Mar 2023
-
-$16.95M(-0.2%)
-$31.57M(-7.2%)
Dec 2022
-$30.14M
-$16.99M(-291.1%)
-$34.02M(-43.5%)
Sep 2022
-
$8.89M(-236.3%)
-$60.23M(-44.4%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$6.52M(-66.4%)
-$108.36M(-26.3%)
Mar 2022
-
-$19.40M(-55.1%)
-$147.10M(-13.0%)
Dec 2021
-$166.72M(+62.5%)
-$43.20M(+10.1%)
-$169.00M(+9.8%)
Sep 2021
-
-$39.24M(-13.3%)
-$153.95M(+8.7%)
Jun 2021
-
-$45.26M(+9.6%)
-$141.60M(+19.5%)
Mar 2021
-
-$41.31M(+46.8%)
-$118.52M(+18.0%)
Dec 2020
-$102.59M(-30.9%)
-$28.14M(+4.6%)
-$100.42M(-12.6%)
Sep 2020
-
-$26.89M(+21.2%)
-$114.85M(+30.6%)
Jun 2020
-
-$22.19M(-4.4%)
-$87.96M(+33.7%)
Mar 2020
-
-$23.21M(-45.5%)
-$65.77M(+54.5%)
Dec 2019
-$148.40M(+45.0%)
-$42.57M
-$42.57M
Dec 2018
-$102.31M
-
-

FAQ

  • What is Immunocore Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Immunocore Holdings?
  • What is Immunocore Holdings annual EBITDA year-on-year change?
  • What is Immunocore Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Immunocore Holdings?
  • What is Immunocore Holdings quarterly EBITDA year-on-year change?
  • What is Immunocore Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Immunocore Holdings?
  • What is Immunocore Holdings TTM EBITDA year-on-year change?

What is Immunocore Holdings annual EBITDA?

The current annual EBITDA of IMCR is -$29.89M

What is the all time high annual EBITDA for Immunocore Holdings?

Immunocore Holdings all-time high annual EBITDA is -$29.89M

What is Immunocore Holdings annual EBITDA year-on-year change?

Over the past year, IMCR annual EBITDA has changed by +$21.76M (+42.13%)

What is Immunocore Holdings quarterly EBITDA?

The current quarterly EBITDA of IMCR is $9.96M

What is the all time high quarterly EBITDA for Immunocore Holdings?

Immunocore Holdings all-time high quarterly EBITDA is $10.91M

What is Immunocore Holdings quarterly EBITDA year-on-year change?

Over the past year, IMCR quarterly EBITDA has changed by +$29.79M (+150.24%)

What is Immunocore Holdings TTM EBITDA?

The current TTM EBITDA of IMCR is $222.00K

What is the all time high TTM EBITDA for Immunocore Holdings?

Immunocore Holdings all-time high TTM EBITDA is $222.00K

What is Immunocore Holdings TTM EBITDA year-on-year change?

Over the past year, IMCR TTM EBITDA has changed by +$54.74M (+100.41%)
On this page